Spectral AI submits CMS NTAP application for DeepView system reimbursement add-on
Bitget2026/10/06 12:32Spectral AI filed an NTAP application with CMS for its DeepView System, seeking add-on Medicare inpatient reimbursement via the alternative pathway. CMS is expected to issue a final decision in August 2027; NTAP status would start in October 2027 if granted. DeepView received FDA De Novo classification in May 2026 for AI-based, non-invasive burn-wound healing assessment. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Spectral Ai Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610060830PRIMZONEFULLFEED9840005) on October 06, 2026, and is solely responsible for the information contained therein.
- Spectral AI filed an NTAP application with CMS for its DeepView System, seeking add-on Medicare inpatient reimbursement via the alternative pathway.
- CMS is expected to issue a final decision in August 2027; NTAP status would start in October 2027 if granted.
- DeepView received FDA De Novo classification in May 2026 for AI-based, non-invasive burn-wound healing assessment.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Analyst Gu Jingci: 10.10 Bitcoin/Ethereum Evening Trading Strategies and Market Analysis
Tekedia Capital flags signs global bond sell-off is losing momentum
Dogecoin ETF to Shut as Bitwise CEO Flags Weak Demand
TD Cowen lowers UnitedHealth target price to $402